WHO | EGIR | AACE | |
---|---|---|---|
Physical component summary (PCS) | |||
Men | |||
Number of individuals with MetS and poor HRQoL(%) | 37 (34.6) | 16 (32.7) | 24 (38.7) |
Adjusted Odds ratio (95 % CI) | |||
Model 1 | 1.89 (1.00–3.57)** | 2.04 (0.83–5.03) | 1.75 (0.82–3.71) |
Model 2 | 1.83 (0.96–3.49)* | 2.05 (0.83–5.07) | 1.72 (0.77–3.84) |
Model 3 | 1.72 (0.88–3.35) | 1.80 (0.69–4.69) | 1.95 (0.84–4.53) |
AUC | 0.64 (0.56–0.73) | 0.66 (0.56–0.75) | 0.66 (0.56–0.76) |
Women | |||
Number of individuals with MetS and poor HRQoL | 70 (35.9) | 30 (30) | 46 (39.3) |
Adjusted Odds ratio (95 % CI) | |||
Model 1 | 1.51 (0.97–2.37)* | 1.21 (0.67–2.19) | 1.56 (0.92–2.64) |
Model 2 | 1.08 (0.67–1.75) | 1.06 (0.57–1.96) | 0.98 (0.55–1.76) |
Model 3 | 0.96 (0.57–1.60) | 0.93 (0.48–1.81) | 1.01 (0.55–1.85) |
AUC | 0.73 (0.68–0.79) | 0.74 (0.67–0.80) | 0.73 (0.67–0.79) |
Mental component summary (MCS) | |||
Men | |||
Number of individuals with MetS and poor HRQoL(%) | 33 (30.8) | 17 (34.7) | 18 (29) |
Adjusted Odds ratio (95 % CI) | |||
Model 1 | 0.92 (0.49–1.73) | 1.16 (0.52–2.59) | 0.74 (0.35–1.58) |
Model 2 | 0.95 (0.50–1.80) | 1.17 (0.52–2.62) | 0.80 (0.36–1.81) |
Model 3 | 0.75 (0.37–1.49) | 0.93 (0.38–2.23) | 0.97 (0.41–2.28) |
AUC | 0.63 (0.54–0.71) | 0.65 (0.55–0.75) | 0.65 (0.55–0.74) |
Women | |||
Number of individuals with MetS and poor HRQoL(%) | 71 (36.4) | 36 (36) | 43 (36.8) |
Adjusted Odds ratio (95 % CI) | |||
Model 1 | 1.14 (0.73–1.77) | 1.15 (0.66–1.99) | 1.25 (0.74–2.12) |
Model 2 | 1.00 (0.63–1.58) | 1.07 (0.61–1.88) | 1.01 (0.57–1.77) |
Model 3 | 0.89 (0.55–1.45) | 0.97 (0.54–1.74) | 1.00 (0.56–1.79) |
AUC | 0.65 (0.59–0.71) | 0.66 (0.59–0.73) | 0.65 (0.59–0.72) |